The Bureau International des Expositions (BIE) announces the official list of candidates for Specialised Expo 2022/23: Poland (Łódź), United States (Minneapolis), Brazil (Rio de Janeiro) and Argentina (Buenos Aires)
The Bureau International des Expositions (BIE) has closed the candidature period for Specialised Expo 2022/23. Four countries have submitted competing bids to organise Specialised Expo 2022/23: the Republic of Poland, the United States of America, the Federative Republic of Brazil and the Republic of Argentina.
The 169 Member States of the BIE will elect the host country of Specialised Expo 2022/23 at the 162nd General Assembly in November 2017.
Poland’s bid is for a Specialised Expo in the city of Łódź between 15 June and 15 September 2022 under the theme “City Re:Invented.”
The United States’ bid is for a Specialised Expo in Minneapolis between 15 May and 15 August 2023 under the theme “Wellness and Well Being for All: Healthy People, Healthy Planet.” The United States is not a Member State of the BIE.*
Brazil’s bid is for a Specialised Expo in Rio de Janeiro between 4 March and 27 May 2022 under the theme “Metropolitan Cities and Sustainability: Cross Border Potentials.”
Argentina’s bid is for a Specialised Expo in Buenos Aires between 15 January and 15 April 2023 under the theme “Science, Innovation, Art and Creativity for the Human Development.”
The Secretary General of the BIE, Vicente G. Loscertales, stated that “these four candidatures demonstrate a high level of interest for this type of Expo.” The project examination phase for Specialised Expo 2022/23 will take place over the next few months. Each candidate will submit a bid dossier, to be followed by a BIE Enquiry Mission. The projects will then be presented to the General Assembly of the BIE on 14 June 2017. The election of the host country by the 169 Member States of the BIE will take place at the subsequent General Assembly in November 2017.
Specialised Expos, known officially as International Recognised Exhibitions, can be organised in the interval between two World Expos. They can last up to three months and are designed to respond to a precise challenge facing humanity. The most recent Specialised Expo was held in the city of Yeosu in the Republic of Korea in 2012, which attracted over 8 million visitors under the theme “The Living Ocean and Coast”. The next Specialised Expo is to take place in Astana, the capital of Kazakhstan, between 10 June and 10 September 2017 under the theme “Future Energy”.
* In accordance with BIE regulations, Member States must be given priority over non-Member States.
The Bureau International des Expositions (BIE) is the intergovernmental organisation embodying the commitment of its 169 member States to lead, promote and foster International Exhibitions for the benefit of the citizens of the international community.
The BIE oversees four types of International Exhibitions: World Expos (International Registered Exhibitions), Specialised Expos (International Recognised Exhibitions), Horticultural Expos and the Triennale di Milano.
International Exhibitions are global events dedicated to finding solutions to specific challenges facing humanity by offering a journey inside the Expo theme through engaging and immersive activities.
Om Business Wire
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Philip Morris International Releases Latest Scientific Update for Smoke-Free Products on Clinical Program12.12.2017 15:23 | Pressemelding
Philip Morris International Inc. (PMI) (NYSE/Euronext Paris: PM) today released its latest Scientific Update for Smoke-Free Products, a regular publication on its research efforts to develop and assess a range of smoke-free alternatives to cigarettes. The latest issue of the Scientific Update can be found at this link. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171212005891/en/ Philip Morris International Releases Latest Scientific Update for Smoke-Free Products on Clinical Program (Photo: Business Wire) This issue of the Scientific Update provides a closer look at some of the principles and practices on which PMI’s scientific assessment program is built. Director Medical Affairs Dr. Patrick Picavet describes specific examples from PMI’s clinical program that highlight the company’s
Murex to Offer MX.3 Risk, Trading and Post-Trade Solutions on the AWS Cloud12.12.2017 14:00 | Pressemelding
Murex, an industry leader in trading, risk management and processing solutions for capital markets, announced they will run their MX.3 technology platform on Amazon Web Services, Inc. (AWS). With the acceleration of cloud adoption in capital markets, Murex and AWS agreed to collaborate to help clients migrate their Murex application workloads to the AWS Cloud. Murex clients are looking to consolidate more and more of their capital markets activity on the MX.3 platform and this means their need for infrastructure is increasing. New regulatory requirements are also driving financial organizations to use cloud to scale up their computing capacity. Murex is collaborating with AWS to meet the demand from clients to support deployment of the Murex offering on the AWS Cloud. Murex is working on the validation of a range of deployment scenarios, from using AWS Cloud for bursting grid
Darzalex®▼(daratumumab) Combination Regimen Significantly Improved Outcomes for Newly Diagnosed Multiple Myeloma Patients who are Transplant Ineligible12.12.2017 13:33 | Pressemelding
Janssen-Cilag International NV (“Janssen”) today announced data from the Phase 3 ALCYONE study, showing Darzalex® (daratumumab) in combination with bortezomib, melphalan and prednisone (VMP) significantly improved clinical outcomes, including reducing the risk of disease progression or death by 50 percent, in patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplantation (ASCT).1 These data were accepted as a late-breaking abstract (LBA) for presentation at the 59th American Society of Hematology (ASH) Annual Meeting in Atlanta, today at 7:30 a.m. ET (Abstract #LBA-4).1 Study findings were simultaneously published in the New England Journal of Medicine (NEJM) . 2 Daratumumab is currently indicated for use in combination with lenalidomide and dexamethasone, or bortezomib and dexamethasone, for
CTS Engines Announces Senior Management Hire12.12.2017 13:00 | Pressemelding
CTS Engines, the global leader for mature jet engine maintenance, announced today that it had hired Diane E. Cavuoto as Senior Vice President, Supply Chain, in an effort to continue to provide its customers with outstanding engine overhaul services. Ms. Cavuoto will be based in CTS’s Ft. Lauderdale headquarters and will report directly to Vesa Paukkeri, CTS’s President and Chief Operating Officer. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171212005050/en/ Diane E. Cavuoto, Senior Vice President, Supply Chain, for CTS Engines (Photo: Business Wire) Ms. Cavuoto, most recently Vice President, Strategic Sourcing at Honeywell International, brings years of supply chain management experience to CTS. In her prior role at Honeywell, Ms. Cavuoto managed a global commodity team of 150 employees managing $4
MIPI Alliance Opens Access to its MIPI I3C Sensor Interface Specification12.12.2017 13:00 | Pressemelding
The MIPI® Alliance, an international organization that develops interface specifications for mobile and mobile-influenced industries, today announced it is opening access to its sensor interface specification, MIPI I3C. Starting today, all companies, including those not currently members of MIPI Alliance, may access the MIPI I3C v1.0 specification so they may evaluate the incorporation of the specification into their sensor integration plans and design applications. “MIPI I3C provides a welcome update to the I2C technology that has been widely adopted over the past 35 years. Extending access provides an opportunity to spur innovation and help other industries beyond mobile," said Joel Huloux, chairman of MIPI Alliance. "It helps MIPI members as well, because it supports greater adoption and interoperability, strengthens the ecosystem and provides for a richer
ADC Therapeutics Announces Interim Phase I Data from its Novel Antibody-Drug Conjugate ADCT-30112.12.2017 11:23 | Pressemelding
ADC Therapeutics (ADCT), an oncology drug discovery and development company that specializes in the development of proprietary Antibody Drug Conjugates (ADCs) targeting major cancers, today announced clinical data from two ongoing Phase I clinical trials evaluating ADCT-301 (camidanlumab tesirine or “Cami-T”) in important subtypes of lymphoma and leukemia. The data were presented at the 59th American Society of Hematology (ASH) Annual Meeting in Atlanta, USA. 1. Interim results of a Phase I open label, single agent, dose-escalating study of ADCT-301 evaluating tolerability, safety, pharmacokinetics and efficacy in patients with relapsed or refractory B-cell Hodgkin’s or non-Hodgkin’s lymphoma Dr. Steven M. Horwitz, Medical Oncologist at Memorial Sloan Kettering Cancer Center in New York City, and Principal Investigator, s
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom